Live Chat

Opere AstraZeneca AZN

AstraZeneca gráfico en tiempo real

instrument_fundamentals

Weekly Search
Weekly
Daily
Date Cerrar Change Cambio del % instr__open Alto Bajo

Markets.com news

bitcoin rising
Alec Malloy 2024 Aug 19, 16:05

Test News Spanish Article Only

BoE Acciones
French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

Adelanto semanal: Los resultados de las elecciones francesas clave para los mercados europeos

Forex Índices
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

Adelanto semanal: ¿Francia desencadenará la próxima crisis del euro?

CPI
Businessman pointing hologram online banking icon.
markets.com Support Team 2024 Jun 20, 16:00

Adelanto semanal: Muchos datos e información sobre la inflación

Forex Índices

Información

Spread

66.25

Spread (%)

0.6407 %

Apalancamiento

1:10

Interés a un día (Compra)

-0.0590 %

Interés a un día (Venta)

-0.0299 %

Divisa

PNC

Horarios de los mercados

Markets closed

Martes

08:01 - 11:59

Lunes

08:01-11:59

Lunes

12:03-16:29

Miércoles

08:01-11:59

Miércoles

12:03-16:29

Jueves

08:01-11:59

Jueves

12:03-16:29

Viernes

08:01-11:59

Viernes

12:03-16:29

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

161574354944

instr__shares_outstand

1550320000

instr__earnings_date

0000-00-00

Div Yield

Ex-Dividend Date

2024-08-08

Forward annual dividend rate

2.34

Forward annual dividend yield

0.0228

instr__eps

3.26

instrument_learn_more

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

related_instruments

Activo
Vender
Comprar
Cambio del %
view_all_instruments
Trustpilot
Live Chat